AI Summary
Thinking
We reviewed 4,610 live results for multi cancer early detection and liquid biopsy and narrowed them down to the 3 options that look most worth comparing first.
The options are SPOT-MAS Multi-Cancer Early Detection, Multi-Cancer Early Detection and Liquid Biopsy and RISE Institute Multi-Cancer Early Detection (MCED) Evaluation.
Source: The Medical City
Description
A liquid biopsy genomic test designed for the early detection of multiple cancer types, offered through a partnership with Gene Solutions at the TMC NGS facility.
Best for
early cancer detection, liquid biopsy screening, high-risk individuals and preventive healthcare
Rate this product
Source: Lucence
Description
Proprietary genomic sequencing technology for detecting cancer signals early and guiding therapeutic selection via non-invasive blood tests.
Best for
early cancer screening, treatment selection, liquid biopsy diagnostics and personalized oncology
Rate this product
Source: National Cancer Centre Singapore (NCCS)
Description
The RISE institute at NCCS evaluates and implements Multi-Cancer Early Detection (MCED) tests, which aim to screen for multiple cancer types simultaneously through advanced blood-based technology.
Best for
early cancer detection, preventative screening, multi-cancer blood tests and research participants
Rate this product
| Compare | #1SPOT-MAS Multi-Cancer Early Detection | #2Multi-Cancer Early Detection and Liquid Biopsy | #3RISE Institute Multi-Cancer Early Detection (MCED) Evaluation |
|---|---|---|---|
| Source | The Medical City | Lucence | National Cancer Centre Singapore (NCCS) |
| Description | A liquid biopsy genomic test designed for the early detection of multiple cancer types, offered through a partnership with Gene Solutions at the TMC NGS facility. | Proprietary genomic sequencing technology for detecting cancer signals early and guiding therapeutic selection via non-invasive blood tests. | The RISE institute at NCCS evaluates and implements Multi-Cancer Early Detection (MCED) tests, which aim to screen for multiple cancer types simultaneously through advanced blood-based technology. |
| Best for | early cancer detection, liquid biopsy screening, high-risk individuals and preventive healthcare | early cancer screening, treatment selection, liquid biopsy diagnostics and personalized oncology | early cancer detection, preventative screening, multi-cancer blood tests and research participants |
| Action | The Medical City | Lucence | National Cancer Centre Singapore (NCCS) |
| Rate this product |
"SPOT-MAS Multi-Cancer Early Detection from The Medical City."
TopFind picked this because TMC combines world-class clinical care with advanced genomic screening for early cancer detection in a hospital-based setting.
Note: TopFind AI compiles product and service information for general comparison purposes only.